Evaluation of the efficacy of a peptide-derived absorbable haemostatic agent in the prevention of post-operative bleeding in artificial ulcers caused by colon and gastric submucosal dissection: a single-centre prospective observational study.

Not Applicable

Recruiting

• Conditions: Early stage colorectal cancer, Early stage gastric cancer

• Registration Number: JPRN-UMIN000050488
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-10
• Last Update Posted: 17 October 2023
• Study Completion: 2030-04-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients with a history of hypersensitivity to peptide or protein preparations. (2) Patients who are considered by the investigator to be unsuitable for participation in this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of posterior bleeding after endoscopic submucosal dissection.